Imikhiqizo
I-Lifecosm Immunological quantification analyzer
| Amandla kagesi: AC 220V 50Hz |
| Ukusebenza kahle kokuhlaziya: <25min |
| Ukunemba: ukuchezuka okuhlobene kungaphakathi kuka-± 15% |
| Ubukhulu: 235X190X120mm |
| Izimo zokugcina: isitoreji ekamelweni lokushisa |
| Umswakama ohlobene: 45% ~ 75% |
| Amandla: <100VA |
| I-Coefficient of variation (CV) ka-1.5% |
| Isixhumi esibonakalayo sedatha: 1 isikhombimsebenzisi sedatha |
| Isisindo: 1.5kg |
| Indawo yokusebenza: izinga lokushisa:-10°C~40°C |
| Umfutho womkhathi: 86.0kPa~106.0kPa |
| Immunological quantification analyzer | |
| Immunological quantification analyzerUkutholwa kwegolide le-Colloidal / fluorescence 2 ku-1 | |
| Inombolo yekhathalogi | EC-01 |
| Isifinyezo | Leli thuluzi liyakwazi ukufunda nokuhlaziya womabili amakhadi okuhlola igolide le-colloidal namakhadi okuhlola e-fluorescent. |
| Isimiso | I-analyzer iqala ngokufunda ulwazi kukhodi enezinhlangothi ezimbili ekhadini Lokuhlola, ihlonze iphepha njengegolide elicwengekileyo, ivule ukukhanya okugqanyiswe yigolide kwe-colloidal (525nm), futhi ikhanyise indawo yokuthola (umugqa we-T) nendawo yokulawula ikhwalithi (umugqa C) ngomzila wokukhanya ohlanganisiwe. |
| Ububanzi besicelo | Lo mkhiqizo usebenzisa ubuchwepheshe be-chromatographic immunoassay futhi uhambisana nokusetshenziswa nekhadi lokuhlola legolide le-fluorescent ne-colloidal." |
| Izinhlelo zokusebenza | Igolide le-Colloidal / fluorescence |
| Isikhathi sokufunda | 10 ~ 15 imizuzu |
| Imiyalo Yokusetshenziswa | Lesi sihlaziyi sisebenzisa isibonisi sesikrini sokuthinta esinamandla ukuze sisebenze, sivumela abasebenzisi ukuthi bazule ezinkethweni zemenyu besebenzisa izinkinobho eziboniswe esikrinini."
|
Amapharamitha wobuchwepheshe bensimbi
| Amandla kagesi: AC 220V 50Hz | Amandla: <100VA |
| Ukusebenza kahle kokuhlaziya: <25min | I-Coefficient of variation (CV) ka-1.5% |
| Ukunemba: ukuchezuka okuhlobene kungaphakathi kuka-± 15% | Isixhumi esibonakalayo sedatha: 1 isikhombimsebenzisi sedatha |
| Ubukhulu: 235X190X120mm | Isisindo: 1.5kg |
| Izimo zokugcina: isitoreji ekamelweni lokushisa | Indawo yokusebenza :izinga lokushisa: -10°C~40°C |
| Umswakama ohlobene: 45% ~ 75% | Umfutho womkhathi: 86.0kPa~106.0kPa |
Izingxenye zesistimu nezakhiwo
Ukuvimbela
Indlela ephumelela kakhulu yokuvimbela ukutheleleka ukuvimbela ukuchayeka kumakati ane-FeLV-athelelekile. Ukuhlola ukuhlonza amakati anegciwane kuyisisekelo esiyinhloko sokuvimbela ukudluliswa kwe-FeLV. Ukugonywa kwe-FeLV akufanele kuthathwe njengokuthatha indawo yokuhlola amakati.
Ulwazi
Izazi ze-Virologists zihlukanisa i-feline immunodeficiency virus (FIV) njenge-lentivirus (noma "igciwane elihamba kancane"). I-FIV isemndenini ofanayo we-retrovirus njenge-feline leukemia virus (FeLV), kodwa amagciwane ahluka ngezindlela eziningi kuhlanganise nokuma kwawo. I-FIV inde, kuyilapho i-FeLV iyindilinga kakhulu. Amagciwane amabili nawo ahluke kakhulu ngokofuzo, futhi amaprotheni awakhayo awafani ngosayizi nangokwakheka kwawo. Izindlela eziqondile ezibanga ngazo izifo ziyehluka, futhi.
Amakati ane-FIV atholakala emhlabeni wonke, kodwa ukwanda kokutheleleka kuyehluka kakhulu. E-United States, cishe amaphesenti angu-1.5 kuya kwangu-3 amakati anempilo angenwe yi-FIV. Amanani akhuphuka kakhulu-amaphesenti angu-15 noma ngaphezulu-emakati agulayo noma asengozini enkulu yokutheleleka. Ngenxa yokuthi ukuluma kuyindlela ephumelela kakhulu yokudlulisela ngegciwane, ukuzulazula mahhala, amakati abesilisa anolaka yiwona avame ukungenwa yilesi sifo, kuyilapho amakati ahlaliswa endlini kuphela mancane amathuba okuthi angenwe yilesi sifo.
Ukudluliswa
Imodi eyinhloko yokudluliselwa kwe-FIV izilonda ezijulile zokulunywa, kuyilapho i-FeLV isakazwa kalula ngokuthintana okuvamile njengokuzilungisa kanye nezitsha zamanzi ezabelwana ngazo.
Ochwepheshe abavumelani ngokuthi i-FIV ingasakazeka ngokuthintana nje. Leli gciwane lisakazwa nangama-mucosal afana nalawo asemlonyeni, e-rectum, nasesithweni sangasese.
Izimpawu
Ekuqaleni kokutheleleka, leli gciwane liyiswa kuma-lymph nodes aseduze, lapho lizala khona kumangqamuzana egazi amhlophe aziwa ngokuthi ama-T-lymphocytes. Igciwane libe selisakazekela kwamanye ama-lymph nodes kuwo wonke umzimba, okuholela ekwandiseni okuvamile kodwa okuvamise ukukhuliswa okwesikhashana kwama-lymph nodes, ngokuvamile okuhambisana nomkhuhlane. Lesi sigaba sokutheleleka singadlula singabonakali ngaphandle uma ama-lymph nodes ekhuliswe kakhulu.
Impilo yekati elinegciwane ingase iwohloke kancane kancane noma ibonakale ngokugula okuphindelelayo okuhlanganiswe nezikhathi zempilo ehlobene. Ngezinye izikhathi zingabonakali iminyaka ngemva kokutheleleka, izimpawu ze-immunodeficiency zingabonakala noma kuphi kuwo wonke umzimba. Izimpawu zimi kanje:
√Isimo esingesihle sejazi kanye nemfiva engapheli evame ukubonakala.
√Ukuvuvukala kwezinsini (gingivitis) kanye nomlomo (stomatitis) kanye nezifo ezingelapheki noma eziphindelelayo zesikhumba, esinyeni somchamo, nomgudu wokuphefumula ongenhla.
√Uhudo olungapheli nakho kungaba yinkinga, kanjalo nezimo ezihlukahlukene zamehlo.
√Ukwehla kwesisindo kancane kancane kodwa okuqhubekayo kuvamile, okulandelwa ukumosha kakhulu sekwephuzile inqubo yesifo.
√Izinhlobo ezahlukene zomdlavuza kanye nezifo zegazi zivame kakhulu kumakati angenwe yi-FIV, futhi.
√Emakati wesifazane angakhokhelwa, ukuphuphunyelwa kwezisu noma okunye ukwehluleka kokuzala kuye kwaphawulwa.
√Amanye amakati angenwe yileli gciwane aba nokuquleka, izinguquko zokuziphatha, nokunye ukuphazamiseka kwemizwa.
Ukuxilongwa
Ukuxilongwa kusekelwe emlandweni, izimpawu zomtholampilo, kanye nomphumela wokuhlolwa kwe-FIV antibody. Ukutholwa kwe-FIV antibody kuwukuhlola okukhethwa kukho, ngoba amazinga egciwane egazini lekati elithelelekile ngokuvamile aphansi kangangokuthi alibonakali ngezindlela ezivamile. Ukuhlola okutholakalayo okwamanje kwe-FIV (i-ELISA, i-Western blot test, nokunye ukuhlola kwe-immunochormatographic) kuthola amasosha omzimba aqondiswe ngokumelene negciwane. Amakati amaningi akha amasosha omzimba afinyelela ku-FIV phakathi nezinsuku ezingama-60 ngemva kokutheleleka. Nokho, isikhathi esidingekayo se-seroconversion siyahlukahluka kakhulu futhi singase sibe side kakhulu kunezinsuku ezingama-60 kwezinye izimo. Ukuhlolwa okuqondile kwe-antibody ye-FIV kubonisa ukuthi ikati linegciwane le-FIV (mhlawumbe ngenxa yezifo zalo ezisungulwe impilo yonke akuvamile ukuqedwa) futhi liyakwazi ukudlulisela igciwane kwamanye amakati asengozini. kufanele kuqashelwe ukuthi amasonto ayisishiyagalombili kuya kwayishumi nambili (futhi ngezinye izikhathi nangaphezulu) angase adlule ngemva kokutheleleka ngaphambi kokuba kubonakale amazinga amasosha omzimba atholakalayo.
Abanye abacwaningi baxwayisa ngokuthi i-pathogenesis yesifo, njengezifo ezibuyela emuva kanye nokuntuleka kokujikeleza kwe-p27 antigen kwamanye amakati anokutheleleka kwe-FeLV, kungenza kube nzima ukuxilongwa okunembile. Ngaphezu kwalokho, ukusetshenziswa kwemijovo ye-FIV kungase futhi kube nzima ukuhlola indawo yokunakekela ngoba ukuhlukana phakathi kwamasosha omzimba abangelwa ukutheleleka kuqhathaniswa nokugonywa kunzima.
Ukuvimbela
Okuwukuphela kwendlela eqinisekile yokuvikela amakati ukuvikela ukuchayeka kwawo egciwaneni. Ukulunywa kwekati kuyindlela enkulu yokutheleleka ngegciwane, ngakho ukugcina amakati esendlini- futhi kude namakati angase abe negciwane angase awalume - kunciphisa ngokuphawulekayo amathuba awo okuthola i-FIV. Ukuze kuphephe amakati ahlala kuwo, amakati angenalo ukutheleleka kuphela okufanele angeniswe ekhaya elinamakati angenalo igciwane.
Imithi yokugoma esiza ukuvikela ekuthelelekeni nge-FIV isiyatholakala. Kodwa-ke, akuwona wonke amakati agonyiwe azovikelwa umgomo, ngakho ukuvimbela ukuchayeka kuzohlala kubalulekile, ngisho nasezifuyweni ezigonyiwe. Ngaphezu kwalokho, ukugoma kungase kube nomthelela emiphumeleni yokuhlolwa ye-FIV yesikhathi esizayo. Kubalulekile ukuthi uxoxe ngezinzuzo kanye nokubi kokugoma nodokotela wakho wezilwane ukuze akusize unqume ukuthi ingabe imigomo ye-FIV kufanele inikezwe ikati lakho.
